GAM Holding AG Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GAM Holding AG lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 39,681 shares of the medical equipment provider’s stock after selling 9,921 shares during the period. Intuitive Surgical makes up approximately 1.6% of GAM Holding AG’s holdings, making the stock its 12th largest holding. GAM Holding AG’s holdings in Intuitive Surgical were worth $19,494,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the stock. Mirador Capital Partners LP grew its stake in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after purchasing an additional 50 shares during the last quarter. Advisors Asset Management Inc. grew its stake in shares of Intuitive Surgical by 18.1% in the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after purchasing an additional 1,129 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after purchasing an additional 76,649 shares during the last quarter. Brookstone Capital Management grew its stake in shares of Intuitive Surgical by 22.4% in the second quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock worth $5,340,000 after purchasing an additional 2,289 shares during the last quarter. Finally, M&G Plc grew its stake in shares of Intuitive Surgical by 53.5% in the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock worth $2,256,000 after purchasing an additional 1,766 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on ISRG shares. Leerink Partners raised their target price on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday. Barclays lifted their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, Wells Fargo & Company lifted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Stock Down 0.3 %

Shares of NASDAQ ISRG opened at $517.50 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $523.34. The firm has a market cap of $183.56 billion, a P/E ratio of 93.41, a PEG ratio of 5.40 and a beta of 1.39. The company has a 50 day moving average of $485.88 and a 200 day moving average of $440.46.

Insider Buying and Selling

In related news, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at approximately $1,461,006.84. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,902 shares of company stock worth $23,596,360 in the last three months. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.